BortiRel (bortezomib) for Injection is a proteasome inhibitor indicated for Multiple Myeloma part of combination therapy for the treatment of patients with previously untreated multiple myeloma who are unsuitable for stem cell transplantation and for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for stem cell transplantation. BortiRel is also indicated for Mantle Cell Lymphoma for the treatment of patients with mantle cell lymphoma who have relapsed or were refractory to at least one prior therapy.
Price:
Thank You!
Thank You for your valuable time. We have received your details and will get back to you shortly.
GST : 27ANQPV9165Q2ZH
For an immediate response, please call this
number 08045817098
Price:
